John Pavlidis has more than 30 years of medical device experience as a senior executive, chief executive and company director in the areas of diagnostic imaging, women's health, image analysis and artificial intelligence, and cardiovascular therapies.
Mr Pavlidis was the president and chief executive of Vytronus Inc, a venture backed startup using novel catheter-based ultrasound and robotics technology to treat atrial fibrillation, a cardiac arrhythmia. Prior to Vytronus, he was the president and chief executive of Endoscopic Technologies Inc until it was acquired by AtriCure Inc in 2014.
Since 2007, he has also served on the board of directors of several health technology companies including U-systems Inc which pioneered automated breast ultrasound imaging as an adjunct to mammography for breast cancer screening and was acquired by GE Healthcare in 2012.